W. K. Lis
Superstar
Coronavirus latest: Moderna vaccine set for US approval this week
From link.
From link.
The coronavirus vaccine candidate made by Moderna is highly protective for adults and prevents severe cases of COVID-19, according to data released by the U.S. Food and Drug Administration.
The FDA review confirms the U.S. drugmaker's earlier assessment that its candidate had an efficacy rate of 94.1% in a trial of 30,000 people.
Based on the encouraging findings, the vaccine likely will receive emergency authorization for use on Friday. That would give millions of Americans access to a second coronavirus vaccine beginning as early as next week.